
Tianjin Medical Journal ›› 2025, Vol. 53 ›› Issue (4): 402-406.doi: 10.11958/20242154
• Clinical Research • Previous Articles Next Articles
FAN Yongjun1(
), LIU Wenfang1, LU Yachao2
Received:2024-12-08
Revised:2025-02-26
Published:2025-04-15
Online:2025-04-17
FAN Yongjun, LIU Wenfang, LU Yachao. Relationship between ventricular arterial coupling and haemodynamics in patients with sepsis and its predictive value for prognosis[J]. Tianjin Medical Journal, 2025, 53(4): 402-406.
CLC Number:
| 时间 | Ea/Ees | CVP/mmHg | SVI/mL | CI/[L/(min·m2)] |
|---|---|---|---|---|
| 0 h | 1.25±0.12 | 4.16±1.73 | 23.19±3.21 | 4.58±1.12 |
| 24 h | 1.21±0.14a | 6.21±1.75a | 27.89±3.32a | 5.26±1.15a |
| 72 h | 1.16±0.16ab | 5.53±1.73ab | 26.37±3.27ab | 4.93±1.12ab |
| F主效应 | 16.785** | 59.285** | 88.385** | 14.849** |
Tab.1 复苏0 h、24 h、72 h的Ea/Ees及血流动力学参数比较 (n=164,$\bar{x} \pm s$)
| 时间 | Ea/Ees | CVP/mmHg | SVI/mL | CI/[L/(min·m2)] |
|---|---|---|---|---|
| 0 h | 1.25±0.12 | 4.16±1.73 | 23.19±3.21 | 4.58±1.12 |
| 24 h | 1.21±0.14a | 6.21±1.75a | 27.89±3.32a | 5.26±1.15a |
| 72 h | 1.16±0.16ab | 5.53±1.73ab | 26.37±3.27ab | 4.93±1.12ab |
| F主效应 | 16.785** | 59.285** | 88.385** | 14.849** |
| 时间 | ΔEa/Ees | ΔCVP/ mmHg | ΔSVI/ mL | ΔCI/[L/ (min·m2)] |
|---|---|---|---|---|
| 24 h | -0.08(-0.11,0.03) | 2.05±0.23 | 4.70±0.84 | 0.67±0.17 |
| 72 h | -0.11(-0.15,0.02) | 1.37±0.20 | 3.17±0.68 | 0.35±0.08 |
| Z或t | 7.024** | 16.912** | 10.560** | 11.614** |
Tab.2 复苏0 h、24 h、72 h的Ea/Ees及血流动力学参数变化情况比较
| 时间 | ΔEa/Ees | ΔCVP/ mmHg | ΔSVI/ mL | ΔCI/[L/ (min·m2)] |
|---|---|---|---|---|
| 24 h | -0.08(-0.11,0.03) | 2.05±0.23 | 4.70±0.84 | 0.67±0.17 |
| 72 h | -0.11(-0.15,0.02) | 1.37±0.20 | 3.17±0.68 | 0.35±0.08 |
| Z或t | 7.024** | 16.912** | 10.560** | 11.614** |
| 指标 | 24 hΔEa/Ees | 指标 | 72 hΔEa/Ees | |
|---|---|---|---|---|
| 24 hΔCVP | -0.654** | 72 hΔCVP | -0.046 | |
| 24 hΔSVI | -0.567** | 72 hΔSVI | -0.082 | |
| 24 hΔCI | -0.451** | 72 hΔCI | -0.073 |
Tab.3 Ea/Ees与脓毒症患者血流动力学指标的相关性分析 (rs)
| 指标 | 24 hΔEa/Ees | 指标 | 72 hΔEa/Ees | |
|---|---|---|---|---|
| 24 hΔCVP | -0.654** | 72 hΔCVP | -0.046 | |
| 24 hΔSVI | -0.567** | 72 hΔSVI | -0.082 | |
| 24 hΔCI | -0.451** | 72 hΔCI | -0.073 |
| 组别 | n | 年龄/岁 | 性别(男/女) | BMI/(kg/m2) | 基础疾病 | 感染部位 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 高血压 | 高脂血症 | 糖尿病 | 冠心病 | 肺部 | 腹部 | 血流 | 其他 | |||||||||||
| 存活组 | 123 | 62.75±3.48 | 66/57 | 23.23±1.56 | 51 | 39 | 35 | 28 | 41 | 35 | 28 | 19 | ||||||
| 死亡组 | 41 | 63.59±3.65 | 23/18 | 23.45±1.69 | 18 | 15 | 14 | 11 | 16 | 11 | 8 | 6 | ||||||
| t或χ2 | 1.319 | 0.074 | 0.729 | 0.075 | 0.331 | 0.475 | 0.280 | 0.477 | ||||||||||
| 组别 | 吸烟史 | 饮酒史 | 血管活性药物 | APACHEⅡ(≥20分/<20分) | SOFA(≥10分/<10分) | 24 hΔEa/Ees | 72 hΔEa/Ees | |||||||||||
| 存活组 | 73 | 67 | 63 | 52/71 | 55/68 | -0.10±0.03 | -0.14±0.05 | |||||||||||
| 死亡组 | 27 | 23 | 26 | 26/15 | 27/14 | 0.15±0.05 | 0.18±0.07 | |||||||||||
| χ2或t | 0.547 | 0.033 | 1.843 | 5.509* | 5.496* | 38.523** | 31.909** | |||||||||||
Tab.4 存活组与死亡组患者基线资料及Ea/Ees指标比较
| 组别 | n | 年龄/岁 | 性别(男/女) | BMI/(kg/m2) | 基础疾病 | 感染部位 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 高血压 | 高脂血症 | 糖尿病 | 冠心病 | 肺部 | 腹部 | 血流 | 其他 | |||||||||||
| 存活组 | 123 | 62.75±3.48 | 66/57 | 23.23±1.56 | 51 | 39 | 35 | 28 | 41 | 35 | 28 | 19 | ||||||
| 死亡组 | 41 | 63.59±3.65 | 23/18 | 23.45±1.69 | 18 | 15 | 14 | 11 | 16 | 11 | 8 | 6 | ||||||
| t或χ2 | 1.319 | 0.074 | 0.729 | 0.075 | 0.331 | 0.475 | 0.280 | 0.477 | ||||||||||
| 组别 | 吸烟史 | 饮酒史 | 血管活性药物 | APACHEⅡ(≥20分/<20分) | SOFA(≥10分/<10分) | 24 hΔEa/Ees | 72 hΔEa/Ees | |||||||||||
| 存活组 | 73 | 67 | 63 | 52/71 | 55/68 | -0.10±0.03 | -0.14±0.05 | |||||||||||
| 死亡组 | 27 | 23 | 26 | 26/15 | 27/14 | 0.15±0.05 | 0.18±0.07 | |||||||||||
| χ2或t | 0.547 | 0.033 | 1.843 | 5.509* | 5.496* | 38.523** | 31.909** | |||||||||||
| 因素 | β | SE | Wald χ2 | P | HR | HR 95%CI |
|---|---|---|---|---|---|---|
| APACHEⅡ | 1.131 | 0.330 | 11.770 | 0.001 | 3.099 | 1.624~5.914 |
| SOFA | 0.700 | 0.225 | 9.664 | 0.002 | 2.013 | 1.295~3.129 |
| 24 hΔEa/Ees | 1.259 | 0.366 | 11.855 | 0.001 | 3.522 | 1.720~7.212 |
| 72 hΔEa/Ees | 0.690 | 0.236 | 8.541 | 0.003 | 1.993 | 1.255~3.165 |
Tab.5 脓毒症患者28 d预后不良的多因素Cox回归分析
| 因素 | β | SE | Wald χ2 | P | HR | HR 95%CI |
|---|---|---|---|---|---|---|
| APACHEⅡ | 1.131 | 0.330 | 11.770 | 0.001 | 3.099 | 1.624~5.914 |
| SOFA | 0.700 | 0.225 | 9.664 | 0.002 | 2.013 | 1.295~3.129 |
| 24 hΔEa/Ees | 1.259 | 0.366 | 11.855 | 0.001 | 3.522 | 1.720~7.212 |
| 72 hΔEa/Ees | 0.690 | 0.236 | 8.541 | 0.003 | 1.993 | 1.255~3.165 |
| 指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
|---|---|---|---|---|---|
| APACHEⅡ | 0.613(0.521~0.699) | 20分 | 63.41 | 57.72 | 0.226 |
| SOFA | 0.602(0.510~0.689) | 10分 | 65.85 | 55.28 | 0.204 |
| 24 hΔEa/Ees | 0.798(0.717~0.865) | 0.12 | 85.32 | 74.58 | 0.570 |
| 72 hΔEa/Ees | 0.811(0.731~0.876) | 0.17 | 75.17 | 77.93 | 0.516 |
Tab.6 APACHEⅡ、SOFA、24 hΔEa/Ees以及72 hΔEa/Ees对脓毒症患者28 d预后的预测价值
| 指标 | AUC(95%CI) | 截断值 | 敏感度/ % | 特异度/ % | 约登 指数 |
|---|---|---|---|---|---|
| APACHEⅡ | 0.613(0.521~0.699) | 20分 | 63.41 | 57.72 | 0.226 |
| SOFA | 0.602(0.510~0.689) | 10分 | 65.85 | 55.28 | 0.204 |
| 24 hΔEa/Ees | 0.798(0.717~0.865) | 0.12 | 85.32 | 74.58 | 0.570 |
| 72 hΔEa/Ees | 0.811(0.731~0.876) | 0.17 | 75.17 | 77.93 | 0.516 |
| [1] | 赵奕琳, 刘田恬, 王春霞. 外泌体参与脓毒症发生发展及临床诊治方面的研究进展[J]. 中华危重病急救医学, 2024, 36(2):221-224. |
| ZHAO Y L, LIU T T, WANG C X. Research advances in exosomes involved in the occurrence,development and clinical diagnosis and treatment of sepsis[J]. Chin Crit Care Med, 2024, 36(2):221-224. doi:10.3760/cma.j.cn121430-20230809-00601. | |
| [2] | FORD V J, APPLEFELD W N, WANG J, et al. Cardiac magnetic resonance studies in a large animal model that simulates the cardiac abnormalities of human septic shock[J]. J Am Heart Assoc, 2024, 13(15):e034026. doi:10.1161/JAHA.123.034026. |
| [3] | 王小燕, 朱雪峰, 陆赵阳, 等. 超声二维斑点追踪成像技术对尿毒症患者心室动脉偶联情况的评估价值[J]. 天津医药, 2021, 49(11):1203-1206. |
| WANG X Y, ZHU X F, LU Z Y, et al. The predictive value of two-dimensional ultrasonic speckle tracking imaging technology for ventricular arterial coupling in uremic patients[J]. Tianjin Med J, 2021, 49(11):1203-1206. doi:10.11958/20203570. | |
| [4] | 欧阳秋芳, 游涛, 许荣, 等. 健心颗粒通过调控Apelin通路对心力衰竭大鼠心室-动脉偶联的影响[J]. 中成药, 2024, 46(1):262-267. |
| OUYANG Q F, YOU T, XU R, et al. Effect of heart-healthy granules on ventricular-arterial coupling in heart failure rats through modulation of the Apelin pathway[J]. Chinese Traditional Patent Medicine, 2024, 46(1):262-267. doi:10.3969/j.issn.1001-1528.2024.01.045. | |
| [5] | ZHOU X, PAN J, WANG Y, et al. Left ventricular-arterial coupling as a predictor of stroke volume response to norepinephrine in septic shock - a prospective cohort study[J]. BMC Anesthesiol, 2021, 21(1):56. doi:10.1186/s12871-021-01276-y. |
| [6] | DEMAILLY Z, BESNIER E, TAMION F, et al. Ventriculo-arterial (un)coupling in septic shock:impact of current and upcoming hemodynamic drugs[J]. Front Cardiovasc Med, 2023,10:1172703. doi:10.3389/fcvm.2023.1172703. |
| [7] | 中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 中国急救医学, 2018, 38(9):741-756. |
| Emergency Physicians Branch of Chinese Physicians Association,Shock and Sepsis Committee of Chinese Society of Research Hospitals. Chinese guidelines for emergency treatment of sepsis/septic shock (2018)[J]. Chin J Crit Care Meb, 2018, 38(9):741-756. doi:10.3969/j.issn.1002-1949.2018.09.001. | |
| [8] | RANJIT S, KISSOON N, ARGENT A, et al. Haemodynamic support for paediatric septic shock:a global perspective[J]. Lancet Child Adolesc Health, 2023, 7(8):588-598. doi:10.1016/S2352-4642(23)00103-7. |
| [9] | LIAN H, LI S, ZHANG Q, et al. U-shaped prognostic value of left ventricular-arterial coupling in septic patients:a prospective study[J]. Eur J Med Res, 2024, 29(1):435. doi:10.1186/s40001-024-02037-6. |
| [10] | 黄玉慧, 张岩, 范春芝, 等. 肾动脉阻力指数联合肺动脉高压对脓毒症患者死亡风险的预测价值[J]. 军事医学, 2024, 48(3):225-229. |
| HUANG Y H, ZHANG Y, FAN C Z, et al. Renal resistive index combined with pulmonary hypertension in assessing mortality risk in sepsis patients[J]. Mil Med Sei, 2024, 48(3):225-229. doi:10.7644/j.issn.1674-9960.2024.03.010. | |
| [11] | 黄浩, 陈湘平, 李程锦, 等. 革兰阴性杆菌感染脓毒症患者B型利钠肽水平与血流动力学参数及炎性因子的相关性[J]. 中国医学科学院学报, 2021, 43(6):879-885. |
| HUANG H, CHEN X P, LI C J, et al. Correlation of B-type natriuretic peptide level with hemodynamic parameters and inflammatory cytokines in patients with gram-negative sepsis[J]. Acta Academiae Medicinae Sinicae, 2021, 43(6):879-885. doi:10.3881/j.issn.1000-503X.14022. | |
| [12] | 董倩倩, 杨燕, 刘德智. 血流动力学参数与脓毒症休克患者容量反应性的预测及相关性分析[J]. 医用生物力学, 2023, 38(6):1219-1225. |
| DONG Q Q, YANG Y, LIU D Z. Prediction and correlation analysis of hemodynamic parameters and volume responsiveness in patients with septic shock[J]. Journal of Medical Biomechanics, 2023, 38(6):1219-1225. doi:10.16156/j.1004-7220.2023.06.025. | |
| [13] | NASU M, SATO R, TAKAHASHI K, et al. The chronological demographics of ventricular-arterial decoupling in patients with sepsis and septic shock:a prospective observational study[J]. J Intensive Care Med, 2023, 38(4):340-348. doi:10.1177/08850666221120219. |
| [14] | YOU J Y, SATO R, CHAWLA S, et al. Hemodynamic profile of cirrhotic patients with sepsis and septic shock:a propensity score matched case-control study[J]. J Crit Care, 2024,81:154532. doi:10.1016/j.jcrc.2024.154532. |
| [15] | MESSINA A, CALABRÒ L, PUGLIESE L, et al. Fluid challenge in critically ill patients receiving haemodynamic monitoring:a systematic review and comparison of two decades[J]. Crit Care, 2022, 26(1):186. doi:10.1186/s13054-022-04056-3. |
| [16] | ZHOU X, ZHANG Y, PAN J, et al. Optimizing left ventricular-arterial coupling during the initial resuscitation in septic shock - a pilot prospective randomized study[J]. BMC Anesthesiol, 2022, 22(1):31. doi:10.1186/s12871-021-01553-w. |
| [17] | KATTAN E, BAKKER J, ESTENSSORO E, et al. Hemodynamic phenotype-based,capillary refill time-targeted resuscitation in early septic shock:the ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol[J]. Rev Bras Ter Intensiva, 2022, 34(1):96-106. doi:10.5935/0103-507X.20220004-pt. |
| [18] | MA Q, DING C, WEI W, et al. The value of right ventricular pulmonary artery coupling in determining the prognosis of patients with sepsis[J]. Sci Rep, 2024, 14(1):15283. doi:10.1038/s41598-024-65738-2. |
| [19] | QIU X, LEI Y P, ZHOU R X. SIRS,SOFA,qSOFA,and NEWS in the diagnosis of sepsis and prediction of adverse outcomes:a systematic review and meta-analysis[J]. Expert Rev Anti Infect Ther, 2023, 21(8):891-900. doi:10.1080/14787210.2023.2237192. |
| [20] | BOWCOCK E M, GERHARDY B, HUANG S, et al. Right ventricular outflow tract Doppler flow analysis and pulmonary arterial coupling by transthoracic echocardiography in sepsis:a retrospective exploratory study[J]. Crit Care, 2022, 26(1):303. doi:10.1186/s13054-022-04160-4. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||